Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by Royce & Associates LP

Royce & Associates LP raised its position in Addus HomeCare Co. (NASDAQ:ADUS) by 1.2% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 8,924 shares of the company’s stock after acquiring an additional 109 shares during the period. Royce & Associates LP’s holdings in Addus HomeCare were worth $1,187,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in ADUS. Victory Capital Management Inc. boosted its holdings in Addus HomeCare by 6.1% in the 3rd quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock valued at $11,302,000 after purchasing an additional 4,913 shares in the last quarter. Entropy Technologies LP acquired a new stake in shares of Addus HomeCare in the 3rd quarter valued at approximately $226,000. WCM Investment Management LLC boosted its stake in shares of Addus HomeCare by 2.9% in the third quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock valued at $65,250,000 after buying an additional 13,938 shares in the last quarter. Versor Investments LP acquired a new position in Addus HomeCare during the third quarter worth $705,000. Finally, Los Angeles Capital Management LLC grew its holdings in Addus HomeCare by 32.6% during the third quarter. Los Angeles Capital Management LLC now owns 11,711 shares of the company’s stock worth $1,558,000 after acquiring an additional 2,879 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. Stephens boosted their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Trading Up 1.6 %

Addus HomeCare stock opened at $120.20 on Wednesday. The stock has a 50-day moving average price of $128.68 and a 200 day moving average price of $122.89. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12. The stock has a market cap of $2.18 billion, a PE ratio of 27.51, a P/E/G ratio of 2.09 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 earnings per share. On average, equities analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 75.23 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 22,917 shares of company stock worth $3,050,082. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.